Genus Capital Management Inc. Sells 33,780 Shares of OR Royalties Inc. $OR

Genus Capital Management Inc. cut its holdings in shares of OR Royalties Inc. (NYSE:OR) by 32.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 71,330 shares of the basic materials company’s stock after selling 33,780 shares during the quarter. Genus Capital Management Inc.’s holdings in OR Royalties were worth $2,530,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Linden Thomas Advisory Services LLC raised its holdings in OR Royalties by 4.1% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 6,254 shares of the basic materials company’s stock valued at $221,000 after acquiring an additional 249 shares during the period. Allworth Financial LP raised its holdings in OR Royalties by 20.0% during the fourth quarter. Allworth Financial LP now owns 2,305 shares of the basic materials company’s stock valued at $82,000 after acquiring an additional 384 shares during the period. Cetera Investment Advisers raised its holdings in OR Royalties by 3.5% during the second quarter. Cetera Investment Advisers now owns 13,147 shares of the basic materials company’s stock valued at $337,000 after acquiring an additional 440 shares during the period. Vident Advisory LLC raised its holdings in OR Royalties by 2.0% during the second quarter. Vident Advisory LLC now owns 42,349 shares of the basic materials company’s stock valued at $1,089,000 after acquiring an additional 820 shares during the period. Finally, Assetmark Inc. bought a new stake in shares of OR Royalties in the fourth quarter worth about $36,000. 68.52% of the stock is owned by institutional investors.

OR Royalties Trading Up 0.0%

Shares of OR stock opened at $35.60 on Monday. OR Royalties Inc. has a 12-month low of $24.76 and a 12-month high of $48.06. The stock’s 50-day moving average price is $38.25 and its 200-day moving average price is $38.46. The stock has a market capitalization of $6.68 billion, a price-to-earnings ratio of 26.57 and a beta of 0.71.

OR Royalties (NYSE:OR) last issued its earnings results on Wednesday, May 6th. The basic materials company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.06. OR Royalties had a return on equity of 15.10% and a net margin of 78.09%.The firm had revenue of $102.83 million for the quarter, compared to analysts’ expectations of $103.27 million. As a group, research analysts predict that OR Royalties Inc. will post 1.4 EPS for the current fiscal year.

OR Royalties Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.065 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This is an increase from OR Royalties’s previous quarterly dividend of $0.06. This represents a $0.26 annualized dividend and a yield of 0.7%. OR Royalties’s payout ratio is presently 16.42%.

Analyst Upgrades and Downgrades

OR has been the topic of several research reports. TD Securities reaffirmed a “hold” rating on shares of OR Royalties in a report on Monday, February 23rd. Scotiabank lifted their target price on OR Royalties from $41.00 to $51.00 and gave the stock a “sector perform” rating in a report on Monday, January 26th. Zacks Research cut OR Royalties from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 31st. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $56.00 target price on shares of OR Royalties in a report on Friday, April 10th. Finally, Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of OR Royalties in a report on Wednesday, February 4th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $46.50.

OR Royalties Company Profile

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.